The therapeutic success of mesenchymal stem cell (MSC) therapy in inflammatory and immune-related diseases is often limited by inconsistent potency between donors, tissues, and cell batches. This paper by Ankrum et al. (Harvard–MIT Division of Health Sciences & Technology) introduces a pioneering method to enhance the immunomodulatory performance of MSC stem cell by delivering glucocorticoid steroids (budesonide and dexamethasone) directly inside the […]
Search Diseases & Conditions....

